These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 7038353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disabling pansclerotic morphea of children.
    Diaz-Perez JL, Connolly SM, Winkelmann RK.
    Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA, Connolly SM, Winkelmann RK.
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Eosinophilic fascitis (Shulman syndrome) in a 13-year-old girl.
    Clemmensen OJ, Thomsen K.
    Acta Derm Venereol; 1980 Nov; 60(3):271-4. PubMed ID: 6158236
    [Abstract] [Full Text] [Related]

  • 6. Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.
    Wollina U, Buslau M, Heinig B, Petrov I, Unger E, Kyriopoulou E, Koch A, Köstler E, Schönlebe J, Haroske G, Doede T, Pramatarov K.
    Int J Low Extrem Wounds; 2007 Dec; 6(4):291-8. PubMed ID: 18048875
    [Abstract] [Full Text] [Related]

  • 7. [Fasciitis eosinophilica--transition to an unusual scleroderma (scleroderma-fasciitis)].
    Jablonska S, Hamm G, Kencka D, Sieminska S.
    Z Hautkr; 1984 Jun 01; 59(11):711-21. PubMed ID: 6485447
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.
    Roldan R, Morote G, Castro Mdel C, Miranda MD, Moreno JC, Collantes E.
    J Rheumatol; 2006 Dec 01; 33(12):2538-40. PubMed ID: 17143989
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Eosinophilic fasciitis--current database].
    Wojas-Pelc A, Wielowieyska-Szybińska D, Lipko-Godlewska S.
    Pol Merkur Lekarski; 2004 Jun 01; 16(96):585-8. PubMed ID: 15510903
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Eosinophilic fasciitis, morphea and vitiligo in a single patient].
    Lakjiri S, Meziane M, Benani A, Harmouch T, Amarti A, Mernissi FZ.
    Ann Dermatol Venereol; 2014 Oct 01; 141(10):598-602. PubMed ID: 25288063
    [Abstract] [Full Text] [Related]

  • 14. [Eosinophilic fasciitis--current knowledge].
    Wojas-Pelc A, Wielowieyska-Szybińska D, Lipko-Godlewska S.
    Przegl Lek; 2003 Oct 01; 60(2):116-9. PubMed ID: 12939859
    [Abstract] [Full Text] [Related]

  • 15. Pansclerotic morphea with features of eosinophilic fasciitis: distinct entities or part of a continuum?
    Odhav A, Hoeltzel MF, Canty K.
    Pediatr Dermatol; 2014 Oct 01; 31(2):e42-7. PubMed ID: 24383741
    [Abstract] [Full Text] [Related]

  • 16. Localized scleroderma: a series of 52 patients.
    Toledano C, Rabhi S, Kettaneh A, Fabre B, Fardet L, Tiev KP, Cabane J.
    Eur J Intern Med; 2009 May 01; 20(3):331-6. PubMed ID: 19393504
    [Abstract] [Full Text] [Related]

  • 17. Deep morphea.
    Bielsa I, Ariza A.
    Semin Cutan Med Surg; 2007 Jun 01; 26(2):90-5. PubMed ID: 17544960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.